Sign In
Buy FWBI
$2.96
+0 (+0%)
At Close: Aug 15, 2024
First Wave BioPharma to Present at Sequire Biotechnology Conference
07:00am, Tuesday, 24'th Jan 2023
BOCA RATON, Fla., Jan. 24, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing
First Wave (FWBI) IND Filing Under FDA's Review, Stock Up
02:18pm, Monday, 16'th Jan 2023
First Wave's (FWBI) stock gains as FDA reviews its IND amendment for the planned phase II study of an enhanced enteric microgranule delivery formulation of adrulipase.
First Wave BioPharma's CEO James Sapirstein to Present at Inaugural Roth Healthcare Opportunities Conference
07:00am, Wednesday, 28'th Sep 2022
BOCA RATON, Fla., Sept. 28, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializ
First Wave BioPharma to Present at H.C. Wainwright 24th Annual Global Investment Conference 2022
07:00am, Monday, 29'th Aug 2022
BOCA RATON, Fla., Aug. 29, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializin
Why First Wave BioPharma Shares Are Tanking Today
08:05am, Monday, 02'nd May 2022
First Wave BioPharma Inc (NASDAQ: FWBI) shares are plummeting after the company reported topline data from Phase 2 RESERVOIR trial of FW-COV, oral formulation of niclosamide, for COVID-19-related GI
Trading Penny Stocks? Top Stock Market News for March 31st, 2022
09:25am, Thursday, 31'st Mar 2022
Here's what you need to know about trading penny stocks on March 31st The post Trading Penny Stocks? Top Stock Market News for March 31st, 2022 appeared first on Penny Stocks to Buy, Picks, News and I
First Wave BioPharma to Participate in the 2022 BIO CEO & Investor Conference
07:30am, Monday, 07'th Feb 2022
BOCA RATON, Fla., Feb. 07, 2022 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializin
First Wave BioPharma Files Two Provisional US Patent Applications For Adrulipase
08:52am, Thursday, 13'th Jan 2022
First Wave BioPharma Inc (NASDAQ: FWBI) has filed two new provisional patent applications on adrulipase with the U.S. Patent and Trademark Office (USPTO). The first application is directed to new
First Wave BioPharma to Participate in Two Investor Conferences in January 2022
07:00am, Tuesday, 04'th Jan 2022
CEO James Sapirstein to Moderate Panel Discussion during Longwood Healthcare Leaders Conference and Host Virtual Presentation at H.C. Wainwright BioConnect 2022 CEO James Sapirstein to Moderate Panel
4 Penny Stocks To Buy For Under $5 Before 2022
11:06am, Friday, 10'th Dec 2021
You can buy these penny stocks for under $5 but are they worth the risk? The post 4 Penny Stocks To Buy For Under $5 Before 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | Pe
First Wave BioPharma Stock Jumps On Niclosamide's Favorable Safety Profile In COVID-19 Related GI Infections
08:33am, Tuesday, 30'th Nov 2021
The independent data monitoring committee (DMC) has recommended First Wave BioPharma Inc (NASDAQ: FWBI) to continue enrollment in Part 2 of the RESERVOIR Phase 2 trial evaluating FW-COV for COVID-1
First Wave BioPharma stock rockets after upbeat news on treatment for COVID-19-related GI infections
08:25am, Tuesday, 30'th Nov 2021
Shares of First Wave BioPharma Inc. FWBI, -2.58% rocketed 46.6% on very heavy volume in premarket trading Tuesday, after the biopharmaceutical company said an independent data monitoring committee (DM
First Wave BioPharma (FWBI) Stock: Why The Price Surged Today
08:16am, Tuesday, 30'th Nov 2021
The stock price of First Wave BioPharma Inc (NASDAQ: FWBI) increased by over 50% pre-market today. This is why it happened.
First Wave BioPharma Set For New Growth Trajectory With GI Pipeline Expansion De-Risking The Investment
07:21pm, Tuesday, 19'th Oct 2021
$229 million acquisition using only $22 million up-front. Low-risk, blockbuster potential GI assets acquired.
BOCA RATON, Fla., Oct. 19, 2021 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializin
